A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis

References

• Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524-529. doi:10.1172/JCI31487
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Quaggin SE, Vaughan DE. Molecular Basis of Organ Fibrosis: Potential Therapeutic Approaches. Exp Biol Med. 2013;238:461-481. doi:10.1177/1535370213489441
   Web of Science ®Google Scholar
• Ghosh AK, Rai R, Flevaris P, Vaughan DE. Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy. J Cell Physiol. 2017;232:1941-1956. doi:10.1002/jcp.25699
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Yuan W, Mori Y, Varga J. Smad-dependent stimulation of Type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene. 2000;19:3546-3555. doi:10.1038/sj.onc.1203693
   PubMed Web of Science ®Google Scholar
• Ghosh AK. FAT-Free p300 is Good for Scar-Free Tissue Repair. J Cell Biochem. 2014;115:1486-1489 doi:10.1002/jcb.24820
   PubMed Web of Science ®Google Scholar
• Yang H, Pinello CE, Luo J, Li D, Wang Y, Zhao LY, Jahn SC, Saldanha SA, Chase P, Planck J, Geary KR, Ma H, Law BK, Roush WR, Hodder P, Liao D. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents. Mol Cancer Ther. 2013;12:610-620. doi:10.1158/1535-7163.MCT-12-0930
   PubMed Web of Science ®Google Scholar
• Nagpal V, Rai R, Place AT, Murphy SB, Verma SK, Ghosh AK, Vaughan DE. MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation. 2016;133:291-301. doi:10.1161/CIRCULATIONAHA.116.022627
   PubMed Web of Science ®Google Scholar
• Kitayama H, Maeshima Y, Takazawa Y, Yamamoto Y, Wu Y, Ichinose K, Hirokoshi K, Sugiyama H, Yamasaki Y, Makino H. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am J Hypertens. 2006;19:718-727. doi:10.1016/j.amjhyper.2005.09.022. PMID:16814127
   PubMed Web of Science ®Google Scholar
• Lavoz C, Rodrigues-Diez R, Benito-Martin A, Rayego-Mateos S, Rodrigues-Diez RR, Alique M, Ortiz A, Mezzano S, Egido J, Ruiz-Ortega M. Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One. 2012;7:e40490. doi:10.1371/journal.pone.0040490. PMID:22792351
   PubMed Web of Science ®Google Scholar
• Arif E, Nihalani D. Podocytes as a therapeutic target. Ann Clin Exp Hypertension. 2013;1(1):1004.
   Google Scholar
• Schnaper WH, Hayashida T, Hubchak SC, Poncelet AC. TGF-β signal transduction and mesangial cell fibrogenesis. AJP – Renal Physiology. 2003;284(2):F243-F252. doi:10.1152/ajprenal.00300.2002
   Google Scholar
• Ghosh AK. Factors involved in Type I collagen gene expression: implication in fibrosis. Exp Biol Med. 2002;227:301-314. doi:10.1177/153537020222700502
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol. 2007;213:663-671. doi:10.1002/jcp.21162
   PubMed Web of Science ®Google Scholar
• Murphy AM, Wong AL, Bezuhly M. Modulation of angiotensin II signaling in the prevention of fibrosis. Fibrogenesis Tissue Repair. 2015;8:7. doi:10.1186/s13069-015-0023-z. PMID:25949522
   PubMed Web of Science ®Google Scholar
• Black JC, Choi JE, Lombardo SR, Carey M.. A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell. 2006;23:809-818. doi:10.1016/j.molcel.2006.07.018
   PubMed Web of Science ®Google Scholar
• Kim SH, Kang HJ, Na H, Lee MO. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. Breast Cancer Res. 2010;12:R22. doi:10.1186/bcr2562. PMID:20388208
   PubMed Web of Science ®Google Scholar
• Kuno A, Hori YS, Hosoda R, Tanno M, Miura T, Shimamoto K, Horio Y. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. J Biol Chem. 2013;288:5963-5972. doi:10.1074/jbc.M112.392050
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Bhattacharyya S, Wei J, Kim S, Barak Y, Mori Y, Varga J. Peroxisome proliferator- activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. FASEB J. 2009;23:2968-2977. doi:10.1096/fj.08-128736
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis. J Invest Dermatol. 2013;133:1302-1310.
   PubMed Web of Science ®Google Scholar
• Hackl MJ, Burford JL, Villanueva K, Lam L, Suszták K, Schermer B, Benzing T, Peti-Peterdi J. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med. 2013;19:1661-1666.
   PubMed Web of Science ®Google Scholar
• Santer FR, Höschele PP, Oh SJ, Erb HH, Bouchal J, Cavarretta IT, Parson W, Meyers DJ, Cole PA, Culig Z. Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer Ther. 2011;10:1644-1655.
   PubMed Web of Science ®Google Scholar
• Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 1998;93:361-372.
   PubMed Web of Science ®Google Scholar
• Dai YS, Markham BE. p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem. 2001;276:37178-37185.
   PubMed Web of Science ®Google Scholar
• Gusterson RJ, Jazrawi E, Adcock IM, Latchman DS. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem. 2003;278:6838-6847.
   PubMed Web of Science ®Google Scholar
• Bansal N. Evolution of Cardiovascular Disease During the Transition to End Stage Renal Disease. Semin Nephrol. 2017;37:120-131.
   PubMed Web of Science ®Google Scholar
• Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, Qin G, Sadayappan S, Ghosh AK, Kishore R. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. Circulation. 2012;126:418-429.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Bradham WS, Gleaves LA, De Taeye B, Murphy SB, Covington JW, Vaughan DE. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to- mesenchymal transition. Circulation. 2010;122:1200-1209.
   PubMed Web of Science ®Google Scholar
• Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002;13:630-638
   PubMed Web of Science ®Google Scholar